StephenAArrigoMD

PubMed

• 1 citations
  Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experienc...
  A. Ricco, Gabrielle Barbera, Rachelle Lanciano, Jing Feng, Alexandra L. Hanlon, Alicia Lozano, Michael Good, Stephen Arrigo, John Lamond, Jun Yang> ;Frontiers in Oncology. 2020 Sep 25
• 8 citations
  Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations.
  A. Ricco, Sara Barlow, Jing Feng, Janson Jacob, Alicia Lozano, Alexandra L. Hanlon, Stephen Arrigo, O. Obayomi-Davies, John Lamond, Jun Yang, Rachelle Lanciano> ;Advances in Radiation Oncology. 2020 Jun 25
• 12 citations
  Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting
  Cory Heal, William Ding, John Lamond, Michael Wong, Rachelle Lanciano, Stacy Su, Jun Yang, Jing Feng, Stephen Arrigo, Deborah Markiewicz, Alexandra L. Hanlon, Luther W...> ;Frontiers in Oncology. 2015 Jun 30
• 25 citations
  Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience
  Shaakir Hasan, Eda Chen, Rachelle Lanciano, Jun Yang, A.L. Hanlon, John Lamond, Stephen Arrigo, William Ding, Michael Mikhail, Arezoo Ghaneie, Luther W. Brady> ;Frontiers in Oncology. 2015 May 15
• 27 citations
  SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN ...
  Matthew Bernetich, Caspian Oliai, Rachelle Lanciano, Alexandra L. Hanlon, John Lamond, Stephen Arrigo, Jun Yang, Michael Good, Jing Feng, Royce Brown, Bruce B. Garber,...> ;Frontiers in Oncology. 2014 Nov 11
• Join now to see all